Replies to post #72946 on Biotech Values

[DewDiligence]

VRTX – It seems to me that they have been talking about collaborating with another oral anti-viral for some time now (a year+?).

My take is that this talk is just lip service to mollify analysts and investors and that VRTX does not really plan to run such trials. I could well be wrong, of course, but this is the signal I’m getting from the body English.